Cannabinoids may induce immunogenic cell death indicating they may be useful in combatting cancer.
This is according to a new study being published in the upcoming issue of the peer-reviewed journal Cannabis and Cannabinoids Research. The study was epublished by the National Institute of Health, and “is the first demonstration that cannabinoids can induce the cell surface expression of ectoCRT, and potentially induce ICD [immunogenic cell death].”
Endogenous and synthetic cannabinoids “have been shown to induce cancer cell death through the accumulation of the sphingolipid, ceramide (Cer)”, states the study. “Recently, we have demonstrated that Cer accumulation enhances the induction of immunogenic cell death (ICD).”
Continue reading